Literature DB >> 20849851

Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells.

Lavinia Nardinocchi1, Rosa Puca, David Givol, Gabriella D'Orazi.   

Abstract

Homeodomain-interacting protein kinase-2 (HIPK2) is a crucial regulator of p53 apoptotic function by phosphorylating serine 46 (Ser46) in response to DNA damage. In tumors with wild-type p53, its tumor suppressor function is often impaired by MDM2 overexpression that targets p53 for proteasomal degradation. Likewise, MDM2 targets HIPK2 for protein degradation impairing p53-apoptotic function. Here we report that zinc antagonised MDM2-induced HIPK2 degradation as well as p53 ubiquitination. The zinc inhibitory effect on MDM2 activity leads to HIPK2-induced p53Ser46 phosphorylation and p53 pro-apoptotic transcriptional activity. These results suggest that zinc derivatives are potential molecules to target the MDM2-induced HIPK2/p53 inhibition.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849851     DOI: 10.1016/j.febslet.2010.09.018

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  GLAD4U: deriving and prioritizing gene lists from PubMed literature.

Authors:  Jérôme Jourquin; Dexter Duncan; Zhiao Shi; Bing Zhang
Journal:  BMC Genomics       Date:  2012-12-17       Impact factor: 3.969

2.  HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation.

Authors:  Lavinia Nardinocchi; Rosa Puca; Gabriella D'Orazi
Journal:  Aging (Albany NY)       Date:  2011-01       Impact factor: 5.682

3.  Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation.

Authors:  Michal Sheffer; Amos J Simon; Jasmine Jacob-Hirsch; Gideon Rechavi; Eytan Domany; David Givol; Gabriella D'Orazi
Journal:  Oncotarget       Date:  2011-12

Review 4.  Role of HIPK2 in kidney fibrosis.

Authors:  Ying Fan; Niansong Wang; Peter Chuang; John C He
Journal:  Kidney Int Suppl (2011)       Date:  2014-11

5.  The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cells.

Authors:  Alessia Garufi; Valentina Ubertini; Francesca Mancini; Valerio D'Orazi; Silvia Baldari; Fabiola Moretti; Gianluca Bossi; Gabriella D'Orazi
Journal:  J Exp Clin Cancer Res       Date:  2015-08-22

Review 6.  Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies.

Authors:  Giuseppa Pistritto; Daniela Trisciuoglio; Claudia Ceci; Alessia Garufi; Gabriella D'Orazi
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

Review 7.  Updates on HIPK2: a resourceful oncosuppressor for clearing cancer.

Authors:  Gabriella D'Orazi; Cinzia Rinaldo; Silvia Soddu
Journal:  J Exp Clin Cancer Res       Date:  2012-08-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.